Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV

BACKGROUND: Dolutegravir, a component of the preferred first-line antiretroviral therapy regimen, has been associated with increased weight gain. South Africa has a high prevalence of obesity, especially among women. Understanding dolutegravir exposure in patients with obesity is important for dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondleki, Enkosi, Banda, Clifford G., Chandiwana, Nomathemba C., Sokhela, Simiso, Wiesner, Lubbe, Venter, Francois, Maartens, Gary, Sinxadi, Phumla Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772744/
https://www.ncbi.nlm.nih.gov/pubmed/36751628
http://dx.doi.org/10.4102/sajhivmed.v23i1.1452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772744/
https://www.ncbi.nlm.nih.gov/pubmed/36751628
http://dx.doi.org/10.4102/sajhivmed.v23i1.1452

Ejemplares similares